Tirzepatide

Research Overview

Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been extensively studied in metabolic research models for its effects on glucose homeostasis, energy balance, and incretin signaling pathways.

Mechanism of Action (Laboratory Research)

Research shows tirzepatide activates both GIP and GLP-1 receptors, leading to enhanced insulin secretion, reduced glucagon levels, and effects on appetite regulation and energy expenditure in metabolic disease models.

Key Published Research Areas

• Dual incretin receptor activation and insulinotropic effects
• Glucose homeostasis and glucagon suppression in metabolic models
• Effects on energy expenditure and body weight regulation
• Incretin pathway research in type 2 diabetes models

Note: All referenced research is from metabolic studies. Sold strictly for laboratory research use only.